Literature DB >> 30343404

Crosstalk Between Sensory Nerves and Cancer in Bone.

Toshiyuki Yoneda1, Masahiro Hiasa2, Tatsuo Okui3.   

Abstract

PURPOSE OF REVIEW: Sensory nerves (SNs) richly innervate bone and are a component of bone microenvironment. Cancer metastasis in bone, which is under the control of the crosstalk with bone microenvironment, induces bone pain via excitation of SNs innervating bone. However, little is known whether excited SNs in turn affect bone metastasis. RECENT
FINDINGS: Cancer cells colonizing bone promote neo-neurogenesis of SNs and excite SNs via activation of the acid-sensing nociceptors by creating pathological acidosis in bone, evoking bone pain. Denervation of SNs or inhibition of SN excitation decreases bone pain and cancer progression and increases survival in preclinical models. Importantly, patients with cancers with increased SN innervation complain of cancer pain and show poor outcome. SNs establish the crosstalk with cancer cells to contribute to bone pain and cancer progression in bone. Blockade of SN excitation may have not only analgesic effects on bone pain but also anti-cancer actions on bone metastases.

Entities:  

Keywords:  Bone microenvironment; Hypoxia; Neo-neurogenesis; Perineural invasion; TRPV1; Warburg effect

Mesh:

Year:  2018        PMID: 30343404     DOI: 10.1007/s11914-018-0489-x

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  78 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain.

Authors:  Roger von Moos; Luis Costa; Carla Ida Ripamonti; Daniela Niepel; Daniele Santini
Journal:  Eur J Cancer       Date:  2016-12-14       Impact factor: 9.162

3.  Osteoclasts play a part in pain due to the inflammation adjacent to bone.

Authors:  Maho Nagae; Toru Hiraga; Hiroki Wakabayashi; Liyang Wang; Koichi Iwata; Toshiyuki Yoneda
Journal:  Bone       Date:  2006-11       Impact factor: 4.398

4.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

5.  Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.

Authors:  D B Mach; S D Rogers; M C Sabino; N M Luger; M J Schwei; J D Pomonis; C P Keyser; D R Clohisy; D J Adams; P O'Leary; P W Mantyh
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 6.  Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling.

Authors:  Kazuharu Irie; Fumiko Hara-Irie; Hidehiro Ozawa; Toshihiko Yajima
Journal:  Microsc Res Tech       Date:  2002-07-15       Impact factor: 2.769

Review 7.  The neurobiology of skeletal pain.

Authors:  Patrick W Mantyh
Journal:  Eur J Neurosci       Date:  2014-02       Impact factor: 3.386

8.  HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.

Authors:  Claire-Sophie Devignes; Yetki Aslan; Audrey Brenot; Audrey Devillers; Koen Schepers; Stéphanie Fabre; Jonathan Chou; Amy-Jo Casbon; Zena Werb; Sylvain Provot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

9.  Repurposing of FDA-approved drugs against cancer - focus on metastasis.

Authors:  Béla Ozsvári; Rebecca Lamb; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

10.  Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis.

Authors:  Mona K Patel; Alan D Kaye; Richard D Urman
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Jan-Mar
View more
  9 in total

1.  The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone.

Authors:  Tatsuo Okui; Masahiro Hiasa; Shoji Ryumon; Kisho Ono; Yuki Kunisada; Soichiro Ibaragi; Akira Sasaki; G David Roodman; Fletcher A White; Toshiyuki Yoneda
Journal:  J Bone Oncol       Date:  2020-10-28       Impact factor: 4.072

Review 2.  Regulation of Carcinogenesis by Sensory Neurons and Neuromediators.

Authors:  Nuray Erin; Galina V Shurin; James H Baraldi; Michael R Shurin
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

3.  Morphine inhibits the promotion of inflammatory microenvironment on chronic tibial cancer pain through the PI3K-Akt-NF-κB pathway.

Authors:  Diyang Ling; Yan Zhao; Zhenwu Zhang; Jiaya Li; Chunhui Zhu; Zheyin Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 4.  Neurophysiological mechanisms of cancer-induced bone pain.

Authors:  Xuan-Qi Zheng; Yu-Hao Wu; Jin-Feng Huang; Ai-Min Wu
Journal:  J Adv Res       Date:  2021-06-11       Impact factor: 10.479

Review 5.  Nervous System-Driven Osseointegration.

Authors:  Ruoyue Sun; Long Bai; Yaru Yang; Yanshu Ding; Jingwen Zhuang; Jingyuan Cui
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 6.  Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer.

Authors:  Boris Mravec
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

7.  The Spinal α7-Nicotinic Acetylcholine Receptor Contributes to the Maintenance of Cancer-Induced Bone Pain.

Authors:  Ting Yang; Yaqun Zhou; Wen Zhang; Longqing Zhang; Shuping Chen; Chao Chen; Feng Gao; Hui Yang; Anne Manyande; Jie Wang; Yuke Tian; Xuebi Tian
Journal:  J Pain Res       Date:  2021-02-15       Impact factor: 3.133

8.  Neurophysiological Mechanisms Related to Pain Management in Bone Tumors.

Authors:  Pablo Romero-Morelos; Erika Ruvalcaba-Paredes; David Garciadiego-Cázares; Martín Pérez-Santos; Samuel Reyes-Long; Alfonso Alfaro-Rodriguez; Mauricio Salcedo; Javier Mancilla-Ramírez; Cindy Bandala
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 9.  Targeting tumor innervation: premises, promises, and challenges.

Authors:  Xinyu Li; Xueqiang Peng; Shuo Yang; Shibo Wei; Qing Fan; Jingang Liu; Liang Yang; Hangyu Li
Journal:  Cell Death Discov       Date:  2022-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.